Chimeric Therapeutics Ltd garners ethics approval for Phase

Chimeric Therapeutics Ltd (ASX:CHM) has the ethics review board’s green light to initiate a multi-site Phase 1B clinical trial of CHM 1101 in patients with...

Related Keywords

California , United States , American , Jason Litten , Chimeric Therapeutics Ltd , City Of Hope Cancer Center , City Of Hope Cancer Centre , American Society Of Clinical Oncology , Hope Cancer , American Society , Clinical Oncology , Central Nervous System Tumors , Hope Cancer Centre ,